Sales 2023 by Business Segment

See more © MarketScreener.com

Sales 2023 by Geography

See more © MarketScreener.com

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (EUR)
Fiscal Period: December2014201520162017201820192020202120222023

Pharmaceutical Products

          

Commercial Areas - Own Network (Europe)

540M 535M 594M 659M 709M

Total Assets

561M 556M 553M 561M 958M

Income Tax Expense

- - - - -

CAPEX

-74.4M - -41.44M -20.42M -

EBT

197M 201M - - -

Gross Profit

377M - - - -

D&A

35.52M 32.86M 32.86M 31.41M 30.87M

Operating Income

197M 201M 260M 263M 270M

Net Income

197M 201M 260M 263M 270M

Commercial Areas - Licensees

111M 147M 114M 86.62M 88.22M

Total Assets

357M 333M 314M 256M 235M

Income Tax Expense

- - - - -

CAPEX

- - - - -

EBT

62.82M 98.44M - - -

Gross Profit

78.96M - - - -

D&A

9.12M 8.4M 8.4M 9.77M 10M

Operating Income

63.62M 98.44M 65.9M 27.11M 29.1M

Net Income

62.82M 98.44M 65.9M 27.11M 29.1M

Commercial Areas - Own Network (United States)

179M 100M 92.49M 74.18M 57.49M

Total Assets

677M 519M 449M 390M 265M

Interest Expense

-594K - - - -

Income Tax Expense

7.4M -16.75M 5.81M 2.6M 1.53M

CAPEX

-14.9M - - -3.15M -

EBT

28.82M -27.83M - - -

Gross Profit

151M - - - -

D&A

52.15M 51.28M 51.82M 48.96M 41.6M

Operating Income

46.61M -27.83M -119M -62.88M -90.11M

Net Income

21.42M -11.07M -125M -65.48M -91.64M

Other Areas - Corporate Services and Manufacturing

79.25M 31.96M 36.21M 59.19M 44.45M

Total Assets

824M 849M 772M 875M 810M

Interest Expense

-21.04M - - - -

Income Tax Expense

14.97M 21.71M 25.96M 24.15M 19.75M

CAPEX

-25.84M -42.4M -31.72M -75.72M -

EBT

-69.82M -115M - - -

Gross Profit

-3.35M - - - -

D&A

16.32M 14.88M 11.59M 14.81M 26.28M

Operating Income

-47.65M -102M -130M -77.62M -103M

Net Income

-84.79M -136M -170M -118M -134M

Other Areas - Research and Development Activity

1.94M 1.07M - - -

Total Assets

28.26M 33.79M 54.35M 65.42M 108M

CAPEX

-1.03M -10.05M -31.33M -28.33M -

EBT

-90.78M -77.8M - - -

Gross Profit

627K - - - -

D&A

5.79M 5.22M 4.71M 4.89M 5M

Operating Income

-90.28M -77.8M -71.91M -103M -111M

Net Income

-90.78M -77.8M -71.91M -103M -111M

Corporate and Other

- - - - -

Income Tax Expense

- - - - -

Total Assets

- - - - -

CAPEX

- - - - -

EBT

- - - - -

Gross Profit

- - - - -

D&A

- - - - -

Operating Income

- - - - -

Net Income

- - - - -

EBT

- - - - -

Gross Profit

58.48M - - - -

D&A

10.52M 10.45M 10.55M 10.8M 10.57M

Operating Income

- - - - -

Net Income

- - - - -

Geographical Revenue Distribution History

Geographical breakdown of sales (EUR)
Fiscal Period: December2014201520162017201820192020202120222023

Spain

243M 237M 250M 274M 297M

Germany

- - - 204M 218M

Other Countries

- - - 192M 177M

Italy

- - - 61.08M 74.83M

United States

- - - 74.18M 57.49M

France

- - - 35.21M 42.71M

United Kingdom

- - - 22.83M 27.8M

Unallocated

26.56M 26.2M 27.09M - -

Europe (Excluding Spain) and The Middle East

357M 394M 407M - -

Corporate Management and Revenue Not Allocated to Other Segments

- - - - -

America, Asia and Africa

228M 150M 143M - -